Paul Braverman Appointed to Leerink Swann Board of Managers

  Paul Braverman Appointed to Leerink Swann Board of Managers

Business Wire

BOSTON -- October 15, 2013

Leerink Swann Holdings, LLC, the parent company of Leerink Swann LLC, a
leading investment bank to both emerging and established companies that are
shaping the future of healthcare, today announced the appointment of former
Wellington Chief Financial Officer, Paul Braverman, to its Board of Managers.

“Paul has had an extraordinarily successful career in financial services and
has extensive board experience across many industries,” said Jeffrey A.
Leerink, Chairman and CEO of Leerink Swann. “His perspective will be
invaluable as we continue to grow the firm’s capabilities.”

Mr. Braverman added, “Leerink Swann has established itself as a leader in
healthcare investment banking with its unparalleled combination of deep domain
knowledge, extensive client relationships and execution excellence. I am
delighted to join the Board at Leerink Swann and look forward to what the firm
can accomplish in the future.”

Mr. Braverman had a 22 year-long tenure as a Partner and CFO at Wellington
Management Company, until his retirement in 2007. Prior to Wellington, he
served as Corporate Pension Manager and Tax Counsel for Digital Equipment
Corporation for eight years and held senior tax positions at Data Terminal
Systems and Arthur Young & Co. Mr. Braverman has also been a Director of
Courier Corporation (Nasdaq: CRRC) since 2009, where he serves on multiple
committees. He also serves on the Boards of Claren Road Asset Management LLC,
MPAM USS Credit Fund Ltd. and Aesir Capital Management, and is a Trustee of
Grantham, Mayo, and Van Otterloo and Co., LLC, an Overseer of the New England
Conservatory, and a member of the Partners HealthCare Real Estate Committee.

Mr. Braverman is an attorney, a member of the Massachusetts Bar Association
and the US Tax Court, and is a Certified Public Accountant. He holds a BS
degree in Business Administration from Boston University and a J.D. degree
from the Boston University School of Law.

About Leerink Swann

Leerink Swann is a leading investment bank to both emerging and established
companies that are shaping the future of healthcare. Focused exclusively on
healthcare, Leerink provides corporate and institutional clients with equity
capital markets and mergers & acquisitions advisory services, equity research
and sales & trading services, and strategic consulting services. Leerink’s
expert knowledge, strategy and insight empowers clients to make well-informed
strategic and investment decisions while paving the way for the innovations
that improve human health. Leerink Swann is a member of FINRA/SIPC. For more
information, please visit: www.leerink.com.

Contact:

Leerink Swann
Molly Gillis, 617-918-4850
molly.gillis@leerink.com
or
Sard Verbinnen & Co
Chris Kittredge, 212-687-8080
CKittredge@SARDVERB.com
 
Press spacebar to pause and continue. Press esc to stop.